Liselotte Nilsson
Ventas & Marketing en CLINICAL LASERTHERMIA SYSTEMS AB .
Cargos activos de Liselotte Nilsson
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CLINICAL LASERTHERMIA SYSTEMS AB | Ventas & Marketing | 01/01/2021 | - |
Historial de carrera de Liselotte Nilsson
Antiguos cargos conocidos de Liselotte Nilsson.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PROSTALUND AB | Ventas & Marketing | - | - |
Svar Life Science AB
 Svar Life Science AB Miscellaneous Commercial ServicesCommercial Services Svar Life Science AB is a Swedish company that provides GMP and non-GMP bioassay services for drug development. The private company is based in Malmö, Sweden. The company specializes in using activity biomarkers to determine if deficiencies, overactivation, or dysregulation in the complement system are causing or contributing to a person's disease or condition. The company offers method development, qualification, validation, and method improvements throughout the drug development lifecycle. Anne Thjømøe has been the CEO of the company since 2022. | Ventas & Marketing | - | - |
| PHASE HOLOGRAPHIC IMAGING PHI AB | Ventas & Marketing | 01/11/2016 | - |
Estadísticas
Internacional
| Suecia | 5 |
Operativa
| Sales & Marketing | 4 |
Sectorial
| Health Technology | 4 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| CLINICAL LASERTHERMIA SYSTEMS AB | Health Technology |
| PHASE HOLOGRAPHIC IMAGING PHI AB | Health Technology |
| PROSTALUND AB | Health Technology |
| Empresas privadas | 1 |
|---|---|
Svar Life Science AB
Svar Life Science AB Miscellaneous Commercial ServicesCommercial Services Svar Life Science AB is a Swedish company that provides GMP and non-GMP bioassay services for drug development. The private company is based in Malmö, Sweden. The company specializes in using activity biomarkers to determine if deficiencies, overactivation, or dysregulation in the complement system are causing or contributing to a person's disease or condition. The company offers method development, qualification, validation, and method improvements throughout the drug development lifecycle. Anne Thjømøe has been the CEO of the company since 2022. | Commercial Services |
- Bolsa de valores
- Insiders
- Liselotte Nilsson
- Experiencia
